Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries

Journal of Sexual Medicine

Volumn 7, Issue 2 PART 1, 2010, Pages 758-768

  Angulo, Javier ^a   González Corrochano, Rocío ^a   Cuevas, Pedro ^a   Fernández, Argentina ^a   Fuente, José M La ^b   Rolo, Francisco ^c   Allona, Antonio ^a   Sáenz de Tejada, Iñigo ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Diabetes; Diabetes and erectile dysfunction; Endothelium; Human corpus cavernosum; Human penile resistance arteries; Nitric oxide

Indexed keywords

ACETYLCHOLINE; CYCLIC GMP; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; SILDENAFIL;

ADULT; AGING; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; ELECTROSTIMULATION; ERECTILE DYSFUNCTION; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MALE GENITAL SYSTEM SURGERY; ORGAN DONOR; PATHOPHYSIOLOGY; PENIS ARTERY; PENIS PROSTHESIS; PRIORITY JOURNAL; PROTEIN CONTENT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; VASODILATATION;

EID: 75649113803     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01587.x     Document Type: Article

References (33)

1. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging study. J Urol 1994, 151:54-61.
2. Martín-Morales A, Sánchez-Cruz JJ, Sáenz de Tejada I, Rodríguez-Vela L, Jiménez-Cruz JF, Burgos-Rodríguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the Epidemiologia de la Disfuncion Erectil Masculina study. J Urol 2001, 166:569-74.
3. Malavige LS, Levy JC. Erectile dysfunction in diabetes mellitus. J Sex Med 2009, 6:1232-47.
4. Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes. A randomized controlled trial. JAMA 1999, 281:421-6.
5. Sáenz de Tejada I, Anglin G, Knight JR, Emmick JT. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 2002, 25:2159-64.
6. Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T. Vardenafil a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: A multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 2003, 26:777-83.
7. Sáenz de Tejada I, Goldstein I, Azadzoi KM, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989, 320:1025-30.
8. Pickard RS, King P, Zar MA, Powell PH. Corpus cavernosal relaxation in impotent men. Br J Urol 1994, 74:485-91.
9. Angulo J, Cuevas P, Fernandez A, Gabancho S, Allona A, Martin-Morales A, Moncada I, Videla S, Saenz de Tejada I. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 2003, 312:1202-8.
10. Pickard RS, Powell PH, Zar MA. Nitric oxide and cyclic GMP formation following relaxant nerve stimulation in isolated human corpus cavernosum. Br J Urol 1995, 75:516-22.
11. Bivalacqua TJ, Hellstrom WJG, Kadowitz PJ, Champion HC. Increased expression of arginase II in human diabetic corpus cavernosum: In diabetic-associated erectile dysfunction. Biochem Biophys Res Commun 2001, 283:923-7.
12. Kim N, Azadzoi KM, Goldstein I, Sáenz de Tejada I. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest 1991, 88:112-8.
13. Angulo J, Peiró C, Cuevas P, Gabancho S, Fernández A, González-Corrochano R, La Fuente JM, Baron AD, Chen KS, Sáenz de Tejada I. The novel antioxidant, AC3056 (2,6-dit-butyl-4-((dimethyl-4-methoxyphenylsilyl)methyloxi)phenol), reverses erectile dysfunction in diabetic rats and improves NO-mediated responses in penile tissue from diabetic men. J Sex Med 2009, 6:373-87.
14. Mulvany MJ, Halpern W. Contractile properties of small resistance arteries in spontaneously hypertensive and normotensive rats. Circ Res 1977, 41:19-26.
15. Elesber AA, Solomon H, Lennon RJ, Mathew V, Prasad A, Pumper G, Nelson RE, McConnell JP, Lerman LO, Lerman A. Coronary endothelial dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J 2006, 27:824-31.
16. De Angelis L, Marfella MA, Siniscalchi M, Marino L, Nappo F, Giugliano F, De Lucia D, Giugliano D. Erectile and endothelial dysfunction in type II diabetes: A possible link. Diabetología 2001, 44:1155-60.
17. Pegge NC, Twomey AM, Vaughton K, Gravenor MB, Ramsey MW, Price DE. The role of endothelial dysfunction in the pathophysiology of erectile dysfunction in diabetes and in determining response to treatment. Diabet Med 2006, 23:873-8.
18. Vardi Y, Dayan L, Apple B, Gruenwald I, Ofer Y, Jacob G. Penile and systemic endothelial function in men with and without erectile dysfunction. Eur Urol 2009, 55:979-85.
19. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992, 326:90-4.
20. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: A physiologic mediator of penile erection. Science 1992, 257:401-3.
21. Trigo-Rocha F, Aronson WJ, Hohenfellner M, Ignarro LJ, Rajfer J, Lue TF. Nitric oxide and cGMP: Mediators of pelvic nerve-stimulated erection in dogs. Am J Physiol 1993, 264:H419-H422.
22. Burnett AL. Role of nitric oxide in the physiology of erection. Biol Reprod 1995, 52:485-9.
23. Angulo J, Cuevas P, Fernández A, Gabancho S, Videla S, Sáenz de Tejada I. Calcium dobesilate potentiates endothelium-derived hyperpolarizing factor-mediated relaxation of human penile resistance arteries. Br J Pharmacol 2003, 139:854-62.
24. Simonsen U, Prieto D, Delgado JA, Hernández M, Resel L, Sáenz de Tejada I, García Sacristán A. Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries. Clin Sci 1997, 92:269-75.
25. Milligan PA, Marshall SF, Karlsson FO. A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction. Br J Clin Pharmacol 2002, 53:45S-52S.
26. Porst H. IC351 (tadalafil, Cialis): Update on clinical experience. Int J Impot Res 2002, 14(1):S57-S64. suppl
27. Corbin JD, Blount MA, Weeks JL, Beasley A, Kuhn KP, Ho YSJ, Saidi LF, Hurley JH, Kotera J, Francis SH. [3H]Sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP. Mol Pharmacol 2003, 63:1364-72.
28. Blount MA, Beasley A, Zoraghi R, Sekhar KS, Bessay EP, Francis SH, Corbin JD. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Mol Pharmacol 2004, 66:144-52.
29. Angulo J, Cuevas P, Fernández A, Allona A, Moncada I, Martín-Morales A, La Fuente JM, Sáenz de Tejada I. Enhanced thromboxane receptor-mediated responses and impaired endothelium-dependent relaxation in human corpus cavernosum from diabetic impotent men: Role of protein kinase C activity. J Pharmacol Exp Ther 2006, 319:783-9.
30. Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J, Hampel N, Polak J, Wang RZ, Ferguson K, Block C, Haas C. Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 1997, 50:1016-26.
31. Rhoden EL, Ribeiro EP, Teloken C, Souto CA. Diabetes mellitus is associated with subnormal serum levels of free testosterone in men. BJU Int 2005, 96:867-70.
32. Fukui M, Soh J, Tanaka M, Kitagawa Y, Hasegawa G, Yoshikawa T, Miki T, Nakamura N. Low serum testosterone concentration in middle-aged men with type 2 diabetes. Endocr J 2007, 54:871-7.
33. Zhang XH, Filippi S, Morelli A, Vignozzi L, Luconi M, Donati S, Forti G, Maggi M. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med 2006, 3:253-64.